The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semiquantitative localisation in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysis.

The novel fluorinated 2-nitroimidazole SR-4554 is undergoing preclinical development as a magnetic resonance spectroscopy and imaging probe for hypoxic tumour cells. We have used electron energy loss spectroscopic analysis (EELS) to show selective reduction and differential subcellular localisation...

Descripción completa

Detalles Bibliográficos
Autores principales: Aboagye, E. O., Lewis, A. D., Johnson, A., Workman, P., Tracy, M., Huxham, I. M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034013/
https://www.ncbi.nlm.nih.gov/pubmed/7640211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034013/
https://www.ncbi.nlm.nih.gov/pubmed/7640211

Ejemplares similares